Viral Clearance Strategies for Biopharmaceutical Safety: Part II: A Multifaceted Approach to Process Validation

被引：0

|

作者：

Aranha, Hazel

Forbes, Sharlene

机构：

来源：

Pharmaceutical Technology | 2001年 / 25卷 / 06期

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：26 / 43

相关论文

共 50 条

[1] Viral clearance strategies for biopharmaceutical safety - Part 3. A multifaceted approach to process validation
Aranha, H
Forbes, S
BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 2001, 14 (05): : 42 - +
[2] Viral clearance strategies for biopharmaceutical safety - Part 2: Filtration for viral clearance
Aranha, H
BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 2001, 14 (02): : 32 - +
[3] Viral clearance strategies for biopharmaceutical safety Part 1: General considerations
Aranha, H
BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 2001, 14 (01): : 28 - 35
[4] Viral safety of biotech products - Developments and challenges of biopharmaceutical viral clearance
Stern, MD
GENETIC ENGINEERING NEWS, 1998, 18 (10): : 26 - +
[5] Viral safety and evaluation of viral clearance from biopharmaceutical products: Goals of the meeting
Seamon, K
VIRAL SAFETY AND EVALUATION OF VIRAL CLEARANCE FROM BIOPHARMACEUTICAL PRODUCTS, 1996, 88 : 3 - 4
[6] International Scientific Conference on Viral Safety and Evaluation of Viral Clearance From Biopharmaceutical Products
Sanhueza, S
VACCINE, 1996, 14 (03) : 244 - 246
[7] Validation strategies for biopharmaceuticals - Viral validation approaches for plasma-derived biopharmaceutical manufacturing processes
Revie, D
Phelan, M
Losikoff, A
Ziomek, C
GENETIC ENGINEERING NEWS, 1999, 19 (08): : 14 - +
[8] Concussion part II: Rehabilitation - The need for a multifaceted approach
Schneider, Kathryn J.
MUSCULOSKELETAL SCIENCE AND PRACTICE, 2019, 42 : 151 - 161
[9] Efficient approach to setting validation acceptance criteria for a biopharmaceutical process
Gleason, Tom
Burdick, Rick
Rausch, Steve
Seely, James E.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
[10] Potential prion risks & clearance by filtration - Strategies for process validation
Aranha, H
Martin, J
GENETIC ENGINEERING NEWS, 2001, 21 (11): : 58 - 59

← 1 2 3 4 5 →